News

Divi Resorts is bringing back its popular Kids Stay & Eat Free program for a limited time! On all-inclusive stays, kids 12 ...
Divi's Labs makes active pharmaceutical ingredients for Entresto for Novartis, which contributes nearly 8% to Hyderabad-based ...
Brokerage firm IIFL has warned that due to this development, Divi's Laboratories' annual Earnings Before Interest, Tax, ...
Entresto is considered a cornerstone of Divi’s innovator-driven custom synthesis portfolio, contributing close to 40 percent ...
Mumbai: The Initial Public Offering (IPO) of Anthem Biosciences Limited opened on July 14 and closed on July 16. The Rs 3,395 crore issue was a complete Offer for Sale (OFS) of 5.96 crore equity ...
Stock recommendations today include HCLTech, Ola Electric, Kalyan Jewellers, and Sun Pharma as analysts review June quarter ...
Dipan Mehta of Elixir Equities suggests the pharma sector is facing headwinds from potential US tariffs, impacting margins ...
The government on Wednesday said that in accordance with the government's directives, all oper­ations of Utility Stores Corpora­tion (USC) will be closed by 31st July, 2025. A high-level meeting of ...
AGNC Investment invests solely in mortgage-backed securities (MBS) protected from credit risk by government agencies like ...
Anthem Biosciences’ IPO puts the spotlight on India’s contract drug manufacturing sector, as investor appetite swells and global firms diversify away from China.
UTI MF sold aggressively in Infosys and in modest quantities in Reliance and Bharti Airtel. The fund’s top 5 stock picks for ...
Anthem Biosciences is a leading player in the fast growing CRDMO (Contract Research, Development and Manufacturing ...